Sharat Chandra

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (8)

• Current State of Allogeneic Hematopoietic Cell Transplantation for Still Disease: A Collaborative Perspective From Attendees of the Systemic Juvenile Idiopathic Arthritis Foundation NextGen Conference
  Arthritis Care & Research 2026 DOI: 10.1002/acr.80191
  +Save
• Novel CSF biomarkers for facilitating diagnosis of CNS-HLH from other neuroinflammatory disorders
  Blood Advances 2026 DOI: 10.1182/bloodadvances.2025016297
  +Save
• Outcomes following matched sibling donor transplantation for severe combined immunodeficiency: a report from the PIDTC
  Ahmad Rayes, Brent R. Logan, Xuerong Liu +50 more
  Blood Advances 2026 DOI: 10.1182/bloodadvances.2025016812
  +Save
• Age Impacts Risk of Mixed Chimerism Following Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Non-Severe Combined Immune Deficiency Inborn Errors of Immunity
  Transplantation and Cellular Therapy 2024 DOI: 10.1016/j.jtct.2023.09.024
  +Save
• HSCT using carrier donors for CD40L deficiency results in excellent immune function and higher CD40L expression in cTfh
  Blood Advances 2022 DOI: 10.1182/bloodadvances.2021006905
  +Save
• High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia
  Blachy J. Dávila Saldaña, Tami D. John, Challice Lee Bonifant

  +26 more

  • David Kyle Buchbinder
  • Sharat Chandra
  • Shanmuganathan Chandrakasan
  • Wen-I Chang
  • Leon Chen
  • +21 more
  Blood Advances 2022 DOI: 10.1182/bloodadvances.2021005291
  +Save
• Test‐dose pharmacokinetics guided melphalan dose adjustment in reduced intensity conditioning allogeneic transplant for non‐malignant disorders
  British Journal of Clinical Pharmacology 2022 DOI: 10.1111/bcp.14932
  +Save
• Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation
  Sharat Chandra, Shanmuganathan Chandrakasan, Blachy J. Dávila Saldaña +8 more
  Journal of Clinical Immunology 2021 DOI: 10.1007/s10875-020-00888-2
  +Save